คอเลสติแลน (Thai Wikipedia)

Analysis of information sources in references of the Wikipedia article "คอเลสติแลน" in Thai language version.

refsWebsite

Global rank Thai rank

2^nd place

4^th place

4^th place

7^th place

1oxfordjournals.org

1,389^th place

1,109^th place

low place

low place

68^th place

166^th place

doi.org

Locatelli, F; Dimkovic, N; Spasovski, G (2013). "Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial" (PDF). Nephrol. Dial. Transplant. 28 (7): 1874–88. doi:10.1093/ndt/gft064. PMC 1.
Handelsman, Y. (2011). "Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes". Diabetes Care. 34: S244–S250. doi:10.2337/dc11-s237. PMID 21525463.
Houten, SM; Watanabe, M; Auwerx, J (2006). "Endocrine functions of bile acids" (PDF). The EMBO Journal. 25: 1419–25. doi:10.1038/sj.emboj.7601049. PMC 1440314.

europa.eu

ec.europa.eu

European Commission (2013). "BindRen, INN-Colestilan" (PDF). European Commission. สืบค้นเมื่อ December 13, 2014.

mims.co.uk

MIMS (December 1, 2013). "BindRen: new phosphate binder". MIMS.co.uk. สืบค้นเมื่อ December 13, 2014.

nih.gov

ncbi.nlm.nih.gov

Locatelli, F; Dimkovic, N; Spasovski, G (2013). "Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial" (PDF). Nephrol. Dial. Transplant. 28 (7): 1874–88. doi:10.1093/ndt/gft064. PMC 1.
Houten, SM; Watanabe, M; Auwerx, J (2006). "Endocrine functions of bile acids" (PDF). The EMBO Journal. 25: 1419–25. doi:10.1038/sj.emboj.7601049. PMC 1440314.

pubmed.ncbi.nlm.nih.gov

Handelsman, Y. (2011). "Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes". Diabetes Care. 34: S244–S250. doi:10.2337/dc11-s237. PMID 21525463.

oxfordjournals.org

ndt.oxfordjournals.org

Locatelli, F; Dimkovic, N; Spasovski, G (2013). "Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial" (PDF). Nephrol. Dial. Transplant. 28 (7): 1874–88. doi:10.1093/ndt/gft064. PMC 1.